Feb. 28, 2017
The approval of the active substance thiabendazole is renewed by the European Commission. The new approval of thiabendazole will expire on March 31, 2032 and the renewal decision will come into force on April 1, 2017.
The EU member states are required to pay particular attention to: the protection of operators and consumers, the protection of groundwater and the control of waste water from post-harvest uses. Conditions of use shall include risk mitigation measures, where appropriate.
The applicant shall submit by 31 March 2019 to the Commission, the member states and the Authority confirmatory information regarding Level 2 tests as currently indicated in the OECD Conceptual Framework investigating the potential for endocrine-mediated effects of thiabendazole.
View More